PSORIASIS AREA SEVERITY INDEX INCREASED

PSORIASIS AREA SEVERITY INDEX INCREASED was reported 165 times

These drug classes are most commonly taken by patients reporting PSORIASIS AREA SEVERITY INDEX INCREASED:

# Drug Count
0 Folate Analog Metabolic Inhibitor [EPC] 49
1 Interleukin-17A Antagonist [EPC] 47
2 Tumor Necrosis Factor Blocker [EPC] 27
3 Interleukin-23 Antagonist [EPC] 16
4 Interleukin-12 Antagonist [EPC] 14
5 Phosphodiesterase 4 Inhibitor [EPC] 13
6 Retinoid [EPC] 13
7 Calcineurin Inhibitor Immunosuppressant [EPC] 9
8 Antirheumatic Agent [EPC] 8
9 Corticosteroid [EPC] 8
10 Benzodiazepine [EPC] 7
11 Interleukin-1 Receptor Antagonist [EPC] 7
12 Interleukin-17 Receptor A Antagonist [EPC] 7
13 Interleukin-36 Receptor Antagonist [EPC] 7
14 Opioid Agonist [EPC] 7
15 Prostaglandin E1 Analog [EPC] 7
16 Tyrosine Kinase 2 Inhibitor [EPC] 7
17 Azole Antifungal [EPC] 6
18 CD20-directed Cytolytic Antibody [EPC] 4
19 Aminosalicylate [EPC] 3
20 HMG-CoA Reductase Inhibitor [EPC] 3
21 5-alpha Reductase Inhibitor [EPC] 2
22 Loop Diuretic [EPC] 2
23 Vitamin B12 [EPC] 2
24 Vitamin C [EPC] 2
25 Vitamin D [EPC] 2
26 Xanthine Oxidase Inhibitor [EPC] 2
27 beta Lactamase Inhibitor [EPC] 2
28 Angiotensin 2 Receptor Blocker [EPC] 1
29 Antimycobacterial [EPC] 1
30 Atypical Antipsychotic [EPC] 1
31 Calcium Channel Blocker [EPC] 1
32 Calcium [EPC] 1
33 Dihydropyridine Calcium Channel Blocker [EPC] 1
34 Erythropoiesis-stimulating Agent [EPC] 1
35 Insulin Analog [EPC] 1
36 Mood Stabilizer [EPC] 1
37 Nonsteroidal Anti-inflammatory Drug [EPC] 1
38 Oxazolidinone Antibacterial [EPC] 1
39 Peroxisome Proliferator Receptor alpha Agonist [EPC] 1
40 Phosphodiesterase 5 Inhibitor [EPC] 1
41 Progesterone [EPC] 1
42 Proton Pump Inhibitor [EPC] 1
43 Provitamin D2 Compound [EPC] 1
44 Purine Antimetabolite [EPC] 1
45 Serotonin-1b and Serotonin-1d Receptor Agonist [EPC] 1
46 Thiazide Diuretic [EPC] 1
47 beta-Adrenergic Blocker [EPC] 1